283 related articles for article (PubMed ID: 24041994)
1. Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
Elbarasi EA; Goodman SG; Yan RT; Tan MK; Hackam DG; Leiter LA; Langer A; Yan AT;
Can J Cardiol; 2013 Dec; 29(12):1586-92. PubMed ID: 24041994
[TBL] [Abstract][Full Text] [Related]
2. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ;
Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947
[TBL] [Abstract][Full Text] [Related]
3. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.
Di Martino M; Degli Esposti L; Filigheddu F; Veronesi C; Salerno G; Saragoni S; Glorioso N; Didoni G; Degli Esposti E
J Hum Hypertens; 2007 Jan; 21(1):53-9. PubMed ID: 17036042
[TBL] [Abstract][Full Text] [Related]
4. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.
Gavish D; Leibovitz E; Elly I; Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Sep; 4(9):694-7. PubMed ID: 12440233
[TBL] [Abstract][Full Text] [Related]
5. Contemporary management of dyslipidemia in high-risk patients: targets still not met.
Yan AT; Yan RT; Tan M; Hackam DG; Leblanc KL; Kertland H; Tsang JL; Jaffer S; Kates ML; Leiter LA; Fitchett DH; Langer A; Goodman SG;
Am J Med; 2006 Aug; 119(8):676-83. PubMed ID: 16887414
[TBL] [Abstract][Full Text] [Related]
6. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
Jaussi A; Noll G; Meier B; Darioli R
Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM
Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
[TBL] [Abstract][Full Text] [Related]
8. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
Bhan V; Yan RT; Leiter LA; Fitchett DH; Langer A; Lonn E; Tan M; Silagy S; Goodman SG; Yan AT;
Am J Cardiol; 2010 Nov; 106(9):1270-6. PubMed ID: 21029823
[TBL] [Abstract][Full Text] [Related]
9. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).
Bourgault C; Davignon J; Fodor G; Gagné C; Gaudet D; Genest J; Lavoie MA; Leiter L; McPherson R; Sénécal M; Marentette M; Sebaldt RJ
Can J Cardiol; 2005 Nov; 21(13):1187-93. PubMed ID: 16308595
[TBL] [Abstract][Full Text] [Related]
11. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
12. Attainment of low-density lipoprotein cholesterol target in the French general population according to levels of cardiovascular risk: Insights from the MONA LISA study.
Bongard V; Dallongeville J; Arveiler D; Ruidavets JB; Amouyel P; Wagner A; Ferrières J
Arch Cardiovasc Dis; 2013 Feb; 106(2):93-102. PubMed ID: 23527913
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
Sukonthasarn A; Homsanit M; Prommete B; Chotinaiwattarakul C; Piamsomboon C; Likittanasombat K
J Med Assoc Thai; 2011 Dec; 94(12):1424-34. PubMed ID: 22295727
[TBL] [Abstract][Full Text] [Related]
14. Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care.
Lee JA; Sunwoo S; Kim YS; Oh HJ; Kang HC; Park KC; Sin DH; Lee SY; Yang YJ; Yu BY; Kim CM
Curr Med Res Opin; 2013 Jul; 29(7):751-60. PubMed ID: 23647398
[TBL] [Abstract][Full Text] [Related]
15. [Achievement of low-density lipoprotein cholesterol therapeutic goal in lipid and vascular risk units of the Spanish Arteriosclerosis Society].
Pedro-Botet J; Mostaza JM; Pintó X; Banegas JR;
Clin Investig Arterioscler; 2013; 25(4):155-63. PubMed ID: 24041476
[TBL] [Abstract][Full Text] [Related]
16. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
Brath H; Wascher TC; Kästenbauer T; Toplak H
MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
[TBL] [Abstract][Full Text] [Related]
17. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
19. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
[TBL] [Abstract][Full Text] [Related]
20. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
Hermida RC; Ayala DE; Fernández JR; Mojón A
Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
